Compound clotrimazole ointment contains clotrimazole. It is a topical cream used to treat candidiasis, tinea versicolor, and dermal infections. It also helps in reducing itching, cracking, and burning in skin caused by infection. Candida (a type of fungus) is the causative agent of candidiasis and tinea versicolor is caused by Malassezia furfur. Clotrimazole is a synthetic antifungal agent. It is an imidazole derivative. It inhibits the biosynthesis of ergosterol, a component of fungal membrane responsible for affecting the cell membrane permeability and enzyme system which in turn causes cell lysis. Chemical name of clotrimazole is {1-(o-Chloro-α,α-diphenylbenzyl)imidazole}. According to the Centers for Disease Control and Prevention, nearly 46,000 cases of invasive candidiasis are reported in the U.S. each year.

Report Overview @ https://www.transparencymarketresearch.com/compound-clotrimazole-ointment-market.html

Broad spectrum of compound clotrimazole creams for dermal infection, rise in prevalence of antifungal infection, increase in awareness about dermal infection and its severity, and advancement in the field of drug discovery & formulation are the factors projected to propel the global compound clotrimazole ointment market during the forecast period. Stringent regulatory guidelines regarding efficacy and safety of compound clotrimazole ointment and contraindications associated with its components for sensitive individuals, and availability of substitutes in the pharmaceutical market are anticipated to restrain the global compound clotrimazole ointment market.

The global compound clotrimazole ointment market can be segmented based on therapeutic application, distribution channel, and region. In terms of therapeutic application, the global market can be classified into candidiasis, tinea versicolor, and others. The others segment includes dermal infections such as athlete’s foot, crotch itch, and ringworm. The candidasis segment dominated the global compound clotrimazole ointment market, as invasive candidasis is the most common form of bloodstream infection. The others segment is projected to be driven by increase in pollution rate and reduction in replicating time of microorganism.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=53595

Based on distribution channel, the global compound clotrimazole ointment market can be categorized into hospital pharmacies, retail pharmacies, online pharmacies, and others. The others segment consists of specialty clinics. The retail pharmacies segment is anticipated to dominate the global market during forecast period due to availability of compound clotrimazole ointment as non-prescription medication in the market. The hospital pharmacies segment is expected to be driven by increase in prescriptions of compound clotrimazole cream to patients by skin specialists and other doctors. The online pharmacies segment is likely to witness strong growth during the forecast period due to rise in preference for online pharmacies due to busy lifestyle of individuals.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=53595

In terms of region, the global compound clotrimazole ointment market can be segmented into North America, Europe, Asia Pacific, Lain America, and Middle East & Africa. North America was the major market for compound clotrimazole ointment in 2017 because of presence of major pharmaceutical players and their well-established research and development infrastructure. Europe was the second leading market because of large number of extensive drug development and formulation based research projects and high awareness and importance among the people about health in the region. Growth of the market in North America and Europe is attributed to high per capital income of individuals in major developed countries in these regions. The market in Asia Pacific is expected to grow at a rapid pace during the forecast period because of rise in prevalence of vaginal candidiasis among women and government initiatives to improve overall health condition in developing countries.

Key players operating in the global compound clotrimazole ointment market include Merck & Co., Inc., GlaxoSmithKline plc, Aidance Skincare & Topical Solutions LLC, Cadila Pharmaceuticals, Alves Health care, and Karnataka Antibiotics & Pharmaceuticals Limited (KAPL).

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]

Website: https://www.transparencymarketresearch.com